For Purchasing Managers, Technical Directors & Operations Leaders: Eliminate high‑price, low‑quality, and slow‑delivery risks while expanding your diabetes‑and‑obesity pipeline.
Get Free Quote in 24 h – Zero CommitmentIn 2025‑2026, the global market for GLP‑1/GIP dual‑agonists surged past USD 12 billion. Yet many corporate buyers still confront the same three bottlenecks:
Imagine a scenario where your R&D team waits 8‑weeks for a 100 g sample, only to discover it fails impurity specifications. The launch timeline extends, marketing budgets swell, and competitors seize market share.
The bottom line: each delay costs roughly USD 150,000 in lost sales per month for a mid‑size pharma.
See the solution that eliminates these risks →| Parameter | Specification |
|---|---|
| CAS Number | 2023788‑19‑2 |
| Molecular Formula | C177H274N50O55S2 |
| Molecular Weight | 4730.8 Da |
| Purity (HPLC) | ≥ 99.5 % (≤ 0.5 % total impurities) |
| Appearance | White to off‑white lyophilized powder |
| Stability | -20 °C to 4 °C, 24 months (shelf‑life) |
| Solubility | Water‑soluble; 5 mg/mL at 25 °C |
| Regulatory Status | FDA‑registered DMF, EMA‑compatible, ISO 13485 (medical device adjunct) |
Scenario 1 – Early‑Stage Clinical Development (Phase I/II)
A US biotech needed 200 g of GMP‑grade Tirzepatide for a dose‑escalation study. Global Technology supplied the material within 10 days, meeting USP ® specifications and enabling the sponsor to file IND two weeks ahead of schedule.
Scenario 2 – Formulation R&D (Oral Peptide Platform)
European partner requested isotopically labeled Tirzepatide (^13C) for PK/PD modeling. Our ODM team delivered a 5 g custom batch with 99 % isotopic enrichment, reducing their analytical turnaround by 35 %.
Scenario 3 – Large‑Scale Commercial Manufacture
An Asian generics company placed a 3‑tonne order for Tirzepatide API. Through our dual‑plant capacity, we achieved a 15 % cost reduction versus their previous supplier and shipped via dedicated container, cutting freight from USD 8 /kg to USD 4 /kg.
Start Your Procurement Journey →The MOQ is **1 g** for research‑grade material and **5 kg** for GMP‑grade batches. Larger volumes receive tiered discounts.
Yes. Our ODM team can produce acetate, tosylate, or ^13C/^15N‑labeled Tirzepatide. Lead time for custom work is 3‑4 weeks.

30 % T/T upfront, 70 % against B/L. For qualified accounts we offer LC, Open Account, or Net‑30 terms.
Each batch is accompanied by a Certificate of Analysis (CoA), DMF dossier excerpt, and GMP audit report. Our regulatory team can co‑author IND/NDA sections.
We partner with DHL Express, FedEx, and UPS for 48‑hour air freight. For bulk orders we offer consolidated containers with door‑to‑door customs clearance.
A dedicated CMC engineer is assigned to every client for the product lifecycle, covering stability studies, scale‑up, and regulatory queries.
Limited‑time Offer: Free 5 g sample + money‑back guarantee if purity < 99.5 %.
Request Sample & Quote NowOr contact us directly: WhatsApp +86 199 4383 0844 | service@huanqiukeji9.com
Linda Gomez, Procurement Lead, BioGenix – “The speed of the 5 g sample delivery (48 h) let us start pre‑clinical work immediately. Pricing was transparent, no hidden fees.”
Mark Liu, Technical Director, Apex Pharma – “Their GMP audit report saved us weeks of internal review. The API met all impurity limits on first try.”
Sarah Patel, Operations Manager, MedCore – “Free freight for orders >10 kg made our cost model 18 % more competitive. The logistics dashboard gave us real‑time visibility.”
Trusted by Industry Leaders
CAS-100111-07-7-Bivalirudin-API CAS-182917-44-8-Hexarelin ACTH-(1-39)-peptide-product-and-supplier 23-Acetyl-alisol-C
All products are manufactured under GMP, ISO 9001, CE, FDA, and RoHS certifications. Full certificates are available on request.